Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5398)
All Articles published online
|
Jul 28, 2010 (publication date) through Dec 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y. Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World J Gastroenterol 2010; 16(28): 3521-3528 [PMID: 20653060 DOI: 10.3748/wjg.v16.i28.3521] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i28/3521.htm |
| Number | Citing Articles |
| 1 |
Feng Chen, Wang Zhang, Xinran Gao, Hui Yuan, Kehai Liu. The Role of Small Interfering RNAs in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2024; 55(1): 26 doi: 10.1007/s12029-023-00911-w
|
| 2 |
Hui‐Lai Miao, Zhi‐Jian Pan, Chang‐Jiang Lei, Ji‐Yu Wen, Ming‐Yi Li, Zhong‐Kao Liu, Zhi‐Dong Qiu, Man‐Zhou Lin, Nian‐Ping Chen, Ming Chen. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down‐regulation of YAP. Journal of Cellular Biochemistry 2013; 114(3): 625 doi: 10.1002/jcb.24404
|
| 3 |
JIAN ZHANG, CHUXIAO SHAO, QINGYUN ZHOU, YIMIN ZHU, JINDE ZHU, CHAOYONG TU. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis. Molecular and Clinical Oncology 2015; 3(5): 1165 doi: 10.3892/mco.2015.600
|
| 4 |
Isabel Theresa Schobert, Lynn Jeanette Savic. Current Trends in Non-Invasive Imaging of Interactions in the Liver Tumor Microenvironment Mediated by Tumor Metabolism. Cancers 2021; 13(15): 3645 doi: 10.3390/cancers13153645
|
| 5 |
Andrew X. Zhu, Philip J. Gold, Anthony B. El-Khoueiry, Thomas A. Abrams, Hideo Morikawa, Norihisa Ohishi, Toshihiko Ohtomo, Philip A. Philip. First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma. Clinical Cancer Research 2013; 19(4): 920 doi: 10.1158/1078-0432.CCR-12-2616
|
| 6 |
Andrew J. Bryant, Elnaz Ebrahimi, Amy Nguyen, Christopher A. Wolff, Michelle L. Gumz, Andrew C. Liu, Karyn A. Esser. A wrinkle in time: circadian biology in pulmonary vascular health and disease. American Journal of Physiology-Lung Cellular and Molecular Physiology 2022; 322(1): L84 doi: 10.1152/ajplung.00037.2021
|
| 7 |
Qiang Lin, Li-wen Xiong, Xu-feng Pan, Jun-feng Gen, Guo-liang Bao, Hui-fang Sha, Jiu-xian Feng, Chun-yu Ji, Ming Chen. Expression of GPC3 protein and its significance in lung squamous cell carcinoma. Medical Oncology 2012; 29(2): 663 doi: 10.1007/s12032-011-9973-1
|
| 8 |
Xiaobo Jia, Jiao Liu, Yingtang Gao, Yong Huang, Zhi Du. Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis. Archives of Medical Research 2014; 45(7): 580 doi: 10.1016/j.arcmed.2014.11.002
|
| 9 |
Weitong Sun, Yong Wang, Mingyue Cai, Liteng Lin, Xiaoyan Chen, Zhong Cao, Kangshun Zhu, Xintao Shuai. Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy. Biomaterials Science 2017; 5(12): 2468 doi: 10.1039/C7BM00866J
|
| 10 |
Leong's Manual of Diagnostic Antibodies for Immunohistology. 2016; : 247 doi: 10.1017/9781139939508.119
|
| 11 |
Min Chen, Guohua Li, Jian Yan, Xiuzhi Lu, Jianwei Cui, Zhengxian Ni, Weizhong Cheng, Gengsun Qian, Jing Zhang, Hong Tu. Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma. Clinica Chimica Acta 2013; 423: 105 doi: 10.1016/j.cca.2013.04.026
|
| 12 |
Carolina M. Vicente, Marcelo A. Lima, Edwin A. Yates, Helena B. Nader, Leny Toma. Enhanced Tumorigenic Potential of Colorectal Cancer Cells by Extracellular Sulfatases. Molecular Cancer Research 2015; 13(3): 510 doi: 10.1158/1541-7786.MCR-14-0372
|
| 13 |
Rafael FERNANDES-FERREIRA, Graciele Domitila TENANI, Marcela Augusta de Souza PINHEL, Ana Margarida Coelho ABRANTES, Maria Filomena Rabaça Roque BOTELHO, Rita de Cássia Martins Alves da SILVA, Dorotéia Rossi Silva SOUZA, Renato Ferreira da SILVA. GENES EXPRESSION AND SERUM BIOMARKERS FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA, CIRRHOSIS AND HEPATITIS C. Arquivos de Gastroenterologia 2022; 59(3): 394 doi: 10.1590/s0004-2803.202203000-71
|
| 14 |
Zainen Qin, Jingjing Wang, Ye Wang, Guohao Wang, Xiangyu Wang, Zhiyang Zhou, Gang Liu, Shi Gao, Lei Zhu. Identification of a Glypican‐3‐Binding Peptide for In Vivo Non‐Invasive Human Hepatocellular Carcinoma Detection. Macromolecular Bioscience 2017; 17(4) doi: 10.1002/mabi.201600335
|
| 15 |
Tayler F. L. Wishart, Frank J. Lovicu. An Atlas of Heparan Sulfate Proteoglycans in the Postnatal Rat Lens. Investigative Opthalmology & Visual Science 2021; 62(14): 5 doi: 10.1167/iovs.62.14.5
|
| 16 |
Joon-Yong Chung. Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation. American Journal of Cancer Research 2024; 14(7): 3348 doi: 10.62347/TTNY4279
|
| 17 |
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, Giuseppe Stefano Calvagno. Hepatocellualar Carcinoma Serum Markers. Seminars in Oncology 2012; 39(4): 410 doi: 10.1053/j.seminoncol.2012.05.001
|
| 18 |
Salma Abdi Mahmoud, Mohammed Mohammed Ibrahim, Ahmed Hago Musa, Yuhong Huang, Jun Zhang, Jingwen Wang, Yuanyi Wei, Li Wang, Shunting Zhou, Boyi Xin, Wei Xuan, Jianwu Tang. Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin. Journal of Cell Communication and Signaling 2018; 12(3): 603 doi: 10.1007/s12079-017-0411-9
|
| 19 |
ZHIJIAN PAN, CHUNZHOU CHEN, HAOCHENG LONG, CHANGJIANG LEI, GANG TANG, LEI LI, JIARUI FENG, FEIXIANG CHEN. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis. Molecular Medicine Reports 2013; 7(3): 969 doi: 10.3892/mmr.2013.1279
|
| 20 |
Wei Gao, Heungnam Kim, Mitchell Ho, Chun-Ming Wong. Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. PLOS ONE 2015; 10(9): e0137664 doi: 10.1371/journal.pone.0137664
|
| 21 |
Mohammed M.H. Al-Gayyar, Ahmed Abbas, Ahmed M. Hamdan. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma. Biological Chemistry 2016; 397(3): 257 doi: 10.1515/hsz-2015-0265
|
| 22 |
Chris K. Sun, Mei-Sze Chua, Jing He, K. So Samuel. Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2. Neoplasia 2011; 13(8): 735 doi: 10.1593/neo.11664
|
| 23 |
Taofic Mounajjed, Lizhi Zhang, Tsung-Teh Wu. Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms. Human Pathology 2013; 44(4): 542 doi: 10.1016/j.humpath.2012.06.016
|
| 24 |
Hui‐Lai Miao, Chang‐Jiang Lei, Zhi‐Dong Qiu, Zhong‐Kao Liu, Ran Li, Shi‐Ting Bao, Ming‐Yi Li. MicroRNA‐520c‐3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican‐3. Hepatology Research 2014; 44(3): 338 doi: 10.1111/hepr.12121
|
| 25 |
Fubo Zhou, Wenting Shang, Xiaoling Yu, Jie Tian. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Medicinal Research Reviews 2018; 38(2): 741 doi: 10.1002/med.21455
|
| 26 |
Tayler F.L. Wishart, Frank J. Lovicu. Heparan sulfate proteoglycans (HSPGs) of the ocular lens. Progress in Retinal and Eye Research 2023; 93: 101118 doi: 10.1016/j.preteyeres.2022.101118
|